相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long non-coding RNA RP11-70C1.3 confers chemoresistance of breast cancer cells through miR-6736-3p/NRP-1 axis
Lansheng Zhang et al.
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES (2022)
Long non-coding RNA FOXD2-AS1 promotes proliferation, migration and invasion of ovarian cancer cells via regulating the expression of miR-4492
Jianfen Gao et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)
PI3K/AKT and MAPK1 molecular changes preceding matrix metallopeptidases overexpression during tamoxifen-resistance development are correlated to poor prognosis in breast cancer patients
Lama Hamadneh et al.
BREAST CANCER (2021)
AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K/AKT/NF-kappa B signaling pathway
Jiayao Qu et al.
CELL AND BIOSCIENCE (2021)
LncRNA XIST promotes chemoresistance of breast cancer cells to doxorubicin by sponging miR-200c-3p to upregulate ANLN
Min Zhang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2020)
The lncRNA-GAS5/miR-221-3p/DKK2 Axis Modulates ABCB1-Mediated Adriamycin Resistance of Breast Cancer via the Wnt/β-Catenin Signaling Pathway
Zhaolin Chen et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer
Qianfeng Shi et al.
NATURE COMMUNICATIONS (2020)
Progress in adjuvant systemic therapy for breast cancer
Noam F. Ponde et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
lncRNA FOXD2-AS1 confers cisplatin resistance of non-small-cell lung cancer via regulation of miR 185-5p-SIX1 axis
Peng Ge et al.
ONCOTARGETS AND THERAPY (2019)
Silencing lncRNA FOXD2-AS1 inhibits proliferation, migration, invasion and drug resistance of drug-resistant glioma cells and promotes their apoptosis via microRNA-98-5p/CPEB4 axis
Naibing Gu et al.
AGING-US (2019)
LncRNA FOXD2-AS1 accelerates the papillary thyroid cancer progression through regulating the miR-485-5p/KLK7 axis
Yayuan Zhang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Phase 1 Dose Escalation Study of the Allosteric AKT Inhibitor BAY 1125976 in Advanced Solid Cancer-Lack of Association between Activating AKT Mutation and AKT Inhibition-Derived Efficacy
Andreas Schneeweiss et al.
CANCERS (2019)
Exosomes from nicotine-stimulated macrophages accelerate atherosclerosis through miR-21-3p/PTEN-mediated VSMC migration and proliferation
Jumo Zhu et al.
THERANOSTICS (2019)
Long noncoding RNA FOXD2-AS1 accelerates the gemcitabine-resistance of bladder cancer by sponging miR-143
Qing An et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Long non-coding RNA FOXD2-AS1 contributes to colorectalcancer proliferation through its interaction withmicroRNA-185-5p
Yanyan Zhu et al.
CANCER SCIENCE (2018)
Upregulation of the long noncoding RNA FOXD2-AS1 promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD1, and predicts poor prognosis in gastric cancer
Tong-peng Xu et al.
ONCOGENE (2018)
The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1
Feng Su et al.
CELL DEATH & DISEASE (2018)
TGF-β promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85α
Anahita Hamidi et al.
SCIENCE SIGNALING (2017)
TGF-β promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85α
Anahita Hamidi et al.
SCIENCE SIGNALING (2017)
PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment
Angel Guerrero-Zotano et al.
CANCER AND METASTASIS REVIEWS (2016)
Artificial Intelligence, Big Data, and Cancer
Hagop Kantarjian et al.
JAMA ONCOLOGY (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Cancer Specific Long Noncoding RNAs Show Differential Expression Patterns and Competing Endogenous RNA Potential in Hepatocellular Carcinoma
Jian Zhang et al.
PLOS ONE (2015)
Dicer-microRNA-Myc circuit promotes transcription of hundreds of long noncoding RNAs
Grace X. Y. Zheng et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)
Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer
Kristina P. Sorensen et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Neoadjuvant Chemotherapy in the Treatment of Breast Cancer
Meredith H. Redden et al.
SURGICAL CLINICS OF NORTH AMERICA (2013)
Prognostic Factors Affecting the Outcome of Salvage Radiotherapy for Isolated Locoregional Recurrence After Mastectomy
Kyubo Kim et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2010)
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Rajnish A. Gupta et al.
NATURE (2010)
Long noncoding RNAs: functional surprises from the RNA world
Jeremy E. Wilusz et al.
GENES & DEVELOPMENT (2009)
A Novel Association between p130Cas and Resistance to the Chemotherapeutic Drug Adriamycin in Human Breast Cancer Cells
Huy Q. Ta et al.
CANCER RESEARCH (2008)
MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer
P Ji et al.
ONCOGENE (2003)
分享论文
